Abiopharma

🔍 HEWSON MARILLYN A (Director)

Company: JOHNSON & JOHNSON (JNJ)

Report Date: 2025-12-09

Detailed Transactions and Holdings:

• Acquired 247 shares of Deferred Share Units (Derivative)
  Date: 2025-12-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 14,153.12 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2

Footnotes:

• F1: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
• F2: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.